15-73702898-A-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001024736.2(CD276):ā€‹c.545A>Cā€‹(p.Gln182Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000774 in 1,614,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q182K) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00043 ( 0 hom., cov: 33)
Exomes š‘“: 0.000041 ( 0 hom. )

Consequence

CD276
NM_001024736.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.375
Variant links:
Genes affected
CD276 (HGNC:19137): (CD276 molecule) The protein encoded by this gene belongs to the immunoglobulin superfamily, and thought to participate in the regulation of T-cell-mediated immune response. Studies show that while the transcript of this gene is ubiquitously expressed in normal tissues and solid tumors, the protein is preferentially expressed only in tumor tissues. Additionally, it was observed that the 3' UTR of this transcript contains a target site for miR29 microRNA, and there is an inverse correlation between the expression of this protein and miR29 levels, suggesting regulation of expression of this gene product by miR29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.027267635).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CD276NM_001024736.2 linkuse as main transcriptc.545A>C p.Gln182Pro missense_variant 4/10 ENST00000318443.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CD276ENST00000318443.10 linkuse as main transcriptc.545A>C p.Gln182Pro missense_variant 4/102 NM_001024736.2 P2Q5ZPR3-1

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152232
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000108
AC:
27
AN:
251154
Hom.:
0
AF XY:
0.0000589
AC XY:
8
AN XY:
135828
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000410
AC:
60
AN:
1461730
Hom.:
0
Cov.:
34
AF XY:
0.0000358
AC XY:
26
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.00137
Gnomad4 AMR exome
AF:
0.000246
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152350
Hom.:
0
Cov.:
33
AF XY:
0.000362
AC XY:
27
AN XY:
74492
show subpopulations
Gnomad4 AFR
AF:
0.00152
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000294
Hom.:
0
Bravo
AF:
0.000521
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000123
AC:
15

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsSep 14, 2021The c.545A>C (p.Q182P) alteration is located in exon 4 (coding exon 3) of the CD276 gene. This alteration results from a A to C substitution at nucleotide position 545, causing the glutamine (Q) at amino acid position 182 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
15
DANN
Benign
0.75
DEOGEN2
Benign
0.038
T;T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.30
N
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Benign
0.0070
T
MetaRNN
Benign
0.027
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
M;.;M
MutationTaster
Benign
1.0
D;D;N;N;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.82
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.15
T;T;T
Sift4G
Benign
0.062
T;T;T
Polyphen
0.93
P;.;P
Vest4
0.43
MVP
0.50
MPC
0.23
ClinPred
0.011
T
GERP RS
-1.0
Varity_R
0.39
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138502254; hg19: chr15-73995239; API